Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Joyce University of Nursing and Health Sciences Salt Lake CityJoyce University Earns 2026 Gold Aetna® Workplace Well-being AwardJoyce recognized at the Gold level for its commitment to employee health and well-being
- MedStar HealthMonumental Sports & Entertainment and MedStar Health Celebrate $1.1 Million Gift to Services Supporting Women, Infants, and Community PediatricsMedStar Health and Monumental Sports & Entertainment (MSE) are proud to continue their philanthropic partnership supporting some of the District's most vulnerable residents. Through a $1.1 million donation, MSE will continue funding MedStar...
- Maximize Market Research Pvt. Ltd.AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market ResearchThe Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion by 2034, according to Maximize Market Research. Global AI in Clinical Trials Market...
- Maximize Market Research Pvt. Ltd.Global Dietary Supplements Market to Reach USD 324.88 Billion by 2034 at 6.37% CAGR as Rising Health Consciousness, Preventive Healthcare, Personalized Nutrition, and Growing Demand for Plant-Based Supplements Accelerate Market Growth, Reports Maximize Market ResearchThe Global Dietary Supplements Market was valued at USD 186.36 Billion in 2025 and is projected to grow at a 6.37% CAGR from 2026 to 2034, reaching USD 324.88 Billion by 2034, according to Maximize Market Research. Global Dietary Supplements...
- Microbot Medical® Highlights Growth StrategyMicrobot Medical® Highlights Growth Strategy
- Toronto Stock ExchangeJack.org Closes the MarketMichael Braithwaite, President and Chief Executive Officer, Jack.org ("Organization"), and his team joined Nicole Popova, Product Lead, TMX Group, to close the market to raise awareness around youth mental health and suicide prevention.Cannot view this video? Visit:https://www.youtube.com/watch?v=G8VX-Pv64WgTimed in recognition of Suicide Prevention Month, the Organization aims to underscore the urgent need to prevent youth suicide, the...
- ArteraNew Data Highlight Artera's MMAI Consistency Across Diverse Patient Populations at ASTRO 2026SAN FRANCISCO, September 25, 2026--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will be featured in new data presented at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.
- NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting AdjustmentsNervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced it will restate its audited annual financial statements for the year ended December 31, 2025, and its unaudited interim financial statements for the quarter ended June 30, 2026.
- BioAge Labs, Inc.BioAge Labs to Present at Upcoming Investor ConferencesBioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:
- Crescent Biopharma Announces Grants of Inducement AwardsCrescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 31,200 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on September 24, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
- AM Best Affirms Credit Ratings of Horace Mann Educators Corporation and Its SubsidiariesOLDWICK, N.J., September 25, 2026--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of the property/casualty (P/C) and life/health (L/H) members of Horace Mann Educators Corporation (HMEC) (headquartered in Springfield, IL). Additionally, AM Best has affirmed the Long-Term ICR of "bbb" (Good) of HMEC and the associated Long-Term Issue Credit Ratings (Long-Term IRs). The outlook of these Credit Rat
- Adicet Bio, Inc.Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus NephritisREDWOOD CITY, Calif., September 25, 2026--Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that the Company will report clinical data from the Phase 1 study evaluating prulacabtagene leucel (prula-cel) as a potential treatment for patients with systemic lupus erythematosus with or without lupus nephriti